The Patent Finder

Cornerstone Therapeutics, Inc.

Also on record
Records under this name other than patents Cornerstone Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cornerstone Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 8,822,472Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof
Formerly held
Lapsed on the fee record
Ended Sep 2, 2026 · High confidence
Lapsed on the fee recordEnded Sep 2, 2026High confidence
US 7,632,500Monoclonal antibodies against HMGB1
Formerly held
Term ended
Term ended Feb 5, 2025 · From the USPTO record
Term endedTerm ended Feb 5, 2025From the USPTO record
US 7,943,622Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof
Formerly held
Lapsed on the fee record
Ended May 17, 2023 · High confidence
Lapsed on the fee recordEnded May 17, 2023High confidence
US 8,846,047Monoclonal antibodies against HMGB1
Formerly held
Lapsed on the fee record
Ended Sep 30, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 30, 2022From the USPTO record
US 8,008,499Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
Formerly held
Lapsed on the fee record
Ended Aug 30, 2019 · From the USPTO record
Lapsed on the fee recordEnded Aug 30, 2019From the USPTO record
US 8,003,684Crystal form and pharmaceutical compositions of (+)-R-zileuton
Lapsed on the fee record
Ended Aug 23, 2019 · From the USPTO record
Lapsed on the fee recordEnded Aug 23, 2019From the USPTO record
US 7,662,965Anabaseine derivatives, pharmaceutical compositions and method of use thereof
Formerly held
Lapsed on the fee record
Ended Feb 16, 2018 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2018From the USPTO record
US 7,470,521RAGE protein derivatives
Formerly held
Lapsed on the fee record
Ended Dec 30, 2016 · From the USPTO record
Lapsed on the fee recordEnded Dec 30, 2016From the USPTO record
US 8,129,130High Affinity Antibodies Against HMGB1 and Methods of Use Thereof
Formerly held
Lapsed on the fee record
Ended Mar 6, 2016 · Medium confidence
Lapsed on the fee recordEnded Mar 6, 2016Medium confidence
US 7,288,250Monoclonal antibodies against HMGB1
Formerly held
Lapsed on the fee record
Ended Oct 30, 2015 · From the USPTO record
Lapsed on the fee recordEnded Oct 30, 2015From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited